What is the Projected CAGR value of the Leukemia Market ?
Leukemia Market is expected to grow at a CAGR of 8.9% during the forecast period 2024-2031.
Who are the key players in Leukemia Market ?
Major players are Pfizer Inc., Eli Lily and Company, F. Hoffmann La Roche, Merck & Co. Inc., Amgen Inc., Radius Health Inc., Teva Pharmaceutical Industries Ltd, GlaxoSmithKline PLC, Novartis International AG, and Actavis PLC.